CXCL9 and hemophagocytic syndrome: Despite the utility of CXCL9 as a diagnostic and a biomarker of IFN-γ activity in primary and secondary HLH, this study revealed that it does not have a significant biological role in pathogenesis of either MAS or FHL murine models.